13 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of 5-benzyl-3-phenyl-4,5-dihydroisoxazoles and 5-benzyl-3-phenyl-1,4,2-dioxazoles as potent firefly luciferase inhibitors.

University of Eastern Finland
Synthesis of an N-acyl sulfamate analog of luciferyl-AMP: a stable and potent inhibitor of firefly luciferase.

Connecticut College
Identification of a naturally occurring quinazolin-4(3H)-one firefly luciferase inhibitor.

Merlion Pharmaceuticals
Discovery, synthesis, and biological evaluation of novel SMN protein modulators.

National Human Genome Research Institute
A basis for reduced chemical library inhibition of firefly luciferase obtained from directed evolution.

National Institutes of Health
False positives in a reporter gene assay: identification and synthesis of substituted N-pyridin-2-ylbenzamides as competitive inhibitors of firefly luciferase.

Leiden/Amsterdam Center For Drug Research
Kinetic Target-Guided Synthesis: Reaching the Age of Maturity.

Univ. Lille
Discovery of an isocoumarin analogue that modulates neuronal functions via neurotrophin receptor TrkB.

Indian Institute of Technology Madras
Identification and synthesis of substituted pyrrolo[2,3-d]pyrimidines as novel firefly luciferase inhibitors.

Chinese Academy of Sciences
Characterization of chemical libraries for luciferase inhibitory activity.

National Human Genome Research Institute
Identification of fused pyrimidines as interleukin 17 secretion inhibitors.

Norwegian University of Science and Technology
Tryptophan hydroxylase inhibitor and pharmaceutical composition including same

Gwangju Institute of Science and Technology
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic.

University of British Columbia